The Lead Episode 76: A Discussion of Asundexian versus Apixaban in Patients with Atrial Fibrillation

Description

Join moderator Melissa Middeldorp as she discusses the NEJM article Asundexian versus Apixaban in Patients with Atrial Fibrillation with Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS at HRS2024 in Atalnta. Brought to you live from the HRSTV Studio, this episode comes with bonus video footage.

Learning Objectives

Compare the use of Asundexian in patients with atrial fibrillation to the use of Apixaban in patients with atrial fibrillation.

Article Authors and Podcast Contributors

Article Authors

Jonathan P. Piccini, M.D., M.H.S., Manesh R. Patel, M.D., Jan Steffel, M.D., Keith Ferdinand, M.D., Isabelle C. Van Gelder, M.D., Ph.D., Andrea M. Russo, M.D., Chang-Sheng Ma, M.D., Shaun G. Goodman, M.D., Jonas Oldgren, M.D., Ph.D., Christopher Hammett, M.B., Ch.B., M.D., Renato D. Lopes, M.D., Ph.D., Masaharu Akao, M.D., Ph.D., Raffaele De Caterina, M.D., Ph.D., Paulus Kirchhof, M.D., Diana A. Gorog, M.D., Ph.D., Martin Hemels, M.D., Michiel Rienstra, M.D., W. Schuyler Jones, M.D., Josephine Harrington, M.D. Gregory Y.H. Lip, M.D., Stephen J. Ellis, Ph.D., Frank W. Rockhold, Ph.D., Christoph Neumann, Ph.D., John H. Alexander, M.D., M.H.S., Thomas Viethen, M.D., M.H.B.A., James Hung, M.D., Rosa Coppolecchia, D.O., M.P.H., Hardi Mundl, M.D., and Valeria Caso, M.D., Ph.D., for the OCEANIC-AF Steering Committee and Investigators

Podcast Contributors

Melissa E. Middeldorp, MPH, PhD, University Medical Centre Groningen & University of Adelaide
Christopher C Cheung, MD, MPH, Sunnybrook Health Sciences Centre, University of Toronto
Prashanthan Sanders, MBBS, PhD, FHRS, University of Adelaide

Faculty and Disclosures

All relevant financial relationships have been mitigated.

Host Disclosure(s):

M. Middeldorp: Nothing to disclose.

Contributor Disclosure(s):
C. Cheung: Nothing to disclose.
P. Sanders: Membership on Advisory Committees: Boston Scientific, Medtronic PLC, Pacemate, CathRx, Research: Abbott, Becton Dickinson, Boston Scientific, CathRx, Medtronic, Pacemate.

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

The Beat Webinar Series - Episode 6 - An Uncommon Case of Idiopathic Left Fascicular Tachycardia (On Demand)

Multiple Credits

FREE

(7)

The Beat Webinar Series - Episode 14 Live from HRX (On-Demand)

No Credit

FREE

The Lead Episode 54: Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants

Multiple Credits

FREE

The Lead Episode 53: Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure

Multiple Credits

FREE

The Lead Episode 52: Retrieval of Chronically Implanted Dual-chamber Leadless Pacemakers in an Ovine Model

Multiple Credits

FREE

The Lead Episode 51: Omnipolar versus bipolar mapping to guide ventricular tachycardia ablation

Multiple Credits

FREE

(2)

The Lead Episode 50: New-onset atrial fibrillation prediction: the HARMS2-AF risk score

Multiple Credits

FREE

The Lead Episode 10: A Discussion of Pulsed Field Ablation for the Treatment of Atrial Fibrillation - PULSED AF Pivotal Trial

No Credit

FREE